Dubuque Bank & Trust’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-45
Closed -$5K – 662
2018
Q3
$5K Sell
45
-46
-51% -$5.19K ﹤0.01% 500
2018
Q2
$11K Hold
91
– – ﹤0.01% 451
2018
Q1
$10K Sell
91
-94
-51% -$10.4K ﹤0.01% 492
2017
Q4
$20K Hold
185
– – ﹤0.01% 429
2017
Q3
$18K Hold
185
– – ﹤0.01% 418
2017
Q2
$19K Hold
185
– – ﹤0.01% 404
2017
Q1
$21K Buy
185
+17
+10% +$1.98K ﹤0.01% 414
2016
Q4
$20K Buy
+168
New +$18.6K ﹤0.01% 335
2015
Q2
– Sell
-223
Closed -$23K – 624
2015
Q1
$23K Hold
223
– – ﹤0.01% 376
2014
Q4
$27K Hold
223
– – ﹤0.01% 370
2014
Q3
$33K Hold
223
– – 0.01% 354
2014
Q2
$37K Buy
+223
New +$39.7K 0.01% 365

Other funds holding CLB

Dubuque Bank & Trust's CLB Position: Q4 2018 in Review

Dubuque Bank & Trust sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 45 shares — an estimated $5K sold.

Dubuque Bank & Trust first reported a position in CLB in Q2 2014 and held it in 12 quarters. The position peaked at $37K in Q2 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Dubuque Bank & Trust reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Dubuque Bank & Trust sold 45 Core Laboratories shares in Q4 2018, an estimated $5K.
  • Dubuque Bank & Trust first reported a position in Core Laboratories in Q2 2014 and held it in 12 quarters.
  • Dubuque Bank & Trust's Core Laboratories position peaked at $37K in Q2 2014.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Dubuque Bank & Trust's 13F filing for Q4 2018, filed 15 Jan 2019.